Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-034969·Whitehawk Therapeutics, Inc.
Schedule 13D ownership disclosure
Whitehawk Therapeutics, Inc.
Common stock, par value $0.0001 per share · CUSIP: 00032Q104
Event date: 2025-03-04
- Filing-level shares
- 2,272,941
- Percent of class
- 4.9%
- Neil DesaiReported CIK 0001878692
Shares: 2,272,941 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-034969
- Form type
- SCHEDULE 13D/A
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Mar 06, 2025
- Reporting period
- Mar 04, 2025
- Description
- Schedule 13D beneficial ownership